ABBV Stock — AbbVie Inc.

AbbVie Inc. (ABBV)

ABBV is a low-cost Stock. As of August 28, 2026, its distribution rate is 2.68%, its trailing-12-month yield is 2.67%. Dividend Vision Distribution Safety Score™ is 99/100 (Safe). Fund total return is 1155.8% over the past 13.7 years, 571.0 points ahead of SPY at 584.8%.

At the current 2.68% distribution rate, a $10,000 investment would generate approximately $268 per year, or $22.33 per month on an equivalent basis. Actual quarterly payments vary.

AbbVie is a research-based biopharmaceutical company that discovers, develops, manufactures, and sells medicines across immunology, oncology, neuroscience, and eye care, with major products including Skyrizi and Rinvoq for autoimmune and inflammatory diseases, Imbruvica and Venclexta for blood cancers, Botox for therapeutic and cosmetic uses, and treatments for conditions ranging from migraine to hepatitis C. The company pays quarterly distributions at a modest current distribution rate. AbbVie appeals to income-focused investors seeking exposure to the pharmaceutical sector.

ABBV performance versus SPY

Data as of August 28, 2026.

Fund total return is 1155.8% over the past 13.7 years, 571.0 points ahead of SPY at 584.8%. Its deepest 1-year drawdown was 17.3%.

ABBV key facts

Data as of August 28, 2026.

Distribution Safety Score™

99 · Safe

Safety-Adjusted Yield

2.65%

Asset type

Stock

Asset class

Equity

Inception date

12/10/2012

Distribution rate

2.68%

Distribution frequency

Quarterly

Trailing yield

2.67%

5-year average yield

3.6

Last close

$255.48

Market cap

$464,575,135,744

Average volume

3222214.0

Last dividend

$1.7300

Ex-dividend date

07/15/2026

Payment date

08/14/2026

Beta

0.28

Payout ratio

0.6283

P/E ratio

75.1143

Forward P/E

18.9036

EPS

$3.50

How Dividend Vision calculates yield and returns

Distribution rate (2.68%) is the latest regular payout annualized by the fund's stated frequency, divided by the last close. Issuers often publish this as “Distribution Rate” on the fact sheet. Trailing-12-month yield (2.67%) is the sum of distributions paid in the last 12 months, split-adjusted, divided by the last close. It lags a recent raise or cut. We show a 30-day SEC yield when the fund publishes one. Schwab and other issuers may report a TTM distribution yield or SEC yield on a different date — all can be valid; they are not interchangeable. Fund total return uses split-adjusted close with distributions reinvested from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is what the fund did, not your personal gain/loss. Figures below use Dividend Vision data as of August 28, 2026.

Distribution rate methodology · Distribution Safety Score methodology · SEC yield

Sources and review

Data as of August 28, 2026.

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

ABBV risks and drawbacks

ABBV's current distribution rate is moderate, not a high-yield payout — the strategy is dividend quality more than maximum income. Payments are quarterly, so cash flow is lumpy versus a monthly fund. The deepest 1-year drawdown on record here is 17.3%.

Who may consider ABBV — and who may not

ABBV may suit someone looking for low-cost broad dividend exposure, a high Distribution Safety Score, moderate current income with a quality tilt. It is a weaker fit for investors who need monthly cash flow (ABBV pays quarterly); investors hunting double-digit covered-call yields. This is educational context, not a recommendation to buy or sell.

Compare ABBV

ABBV vs similar funds:

• ABBV vs ABT
• ABBV vs JNJ

Frequently asked questions